ZYMENEX ApS: Financial statements 2016
CVR: 27394752
ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 49,052,000 and a net result of DKK 294,360,000 compared with DKK 656,421 the year before. The profit margin was 600.1%. Equity amounted to DKK 230,260,000. The solvency ratio was 64%.
- Revenue
- 49,052,000 kr.
- Gross Profit
- 49,052,000 kr.
- Profit/Loss
- 294,360,000 kr.
- Equity
- 230,260,000 kr.
- Total Assets
- 360,029,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 49.1 mio. | 49.1 mio. | 294.4 mio. | 230.3 mio. | - |
| 2015 | - | -52.5 mio. | 656 t. | -64.1 mio. | - |
| 2014 | - | -67.9 mio. | 1.1 mio. | -64.8 mio. | - |
| 2013 | - | - | -33.8 mio. | -65.8 mio. | - |
| 2012 | - | - | -42 mio. | -32.1 mio. | - |
How creditworthy is ZYMENEX ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of July 29, 2016, Natallia Misuna has left the board of directors of ZYMENEX ApS.
As of May 17, 2016, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ZYMENEX ApS.
As of May 17, 2016, KPMG P/S has stepped down as auditor of ZYMENEX ApS.
ZYMENEX ApS has published its annual report for 2015. Gross profit came to DKK -52,501,446, and the net result was DKK 656,421.
About ZYMENEX ApS
ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity amounted to DKK 82,550,000.
